Barriers remain for those seeking buprenorphine treatment for opioid use disorder, despite rapid access in some Philadelphia clinics. A recent study led by Maggie Lowenstein, Shoshana Aronowitz, and team highlights gaps in communication that leave patients without crucial information. Improving transparency is essential for informed care decisions.
Barriers Remain in Accessing Buprenorphine for Opioid Treatment, Study Finds
